Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: |
Rilutek |
Note: This consent is given subject to the following condition: Rilutek can only be prescribed by specialist physicians who care for patients with Motor Neurone Disease, neurologists and palliative care physicians. Note: This renewed consent is valid for two years from 4 April 2015. |
|
Product: |
Verorab |
Note: This renewed consent is valid for two years from 27 January 2015.
Dated this 3rd day of December 2014.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).